Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.20+0.07 (+0.77%)
Close on Nov 17, 2026Market cap $821.53MP/E –Yield –
Syndax Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Syndax Pharmaceuticals's price to sales ratio was 3.4× on Nov 11, 2026, against 15.4× a year earlier. Over the last 5 years it ranged from 3.4× to 499.2×, with a median of 59.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.4× | −13.0 |
| 2025 | Dec 31, 2025 | 16.4× | −54.3 |
| 2024 | Dec 31, 2024 | 70.7× | +64.1 |
| 2022 | Apr 29, 2022 | 6.6× | −72.5 |
| 2021 | Dec 31, 2021 | 79.1× | −362.9 |
| 2020 | Oct 30, 2020 | 442.0× | +284.9 |
| 2019 | Dec 31, 2019 | 157.1× | +111.1 |
| 2018 | Dec 31, 2018 | 45.9× | −114.3 |
| 2017 | Dec 29, 2017 | 160.2× | +53.4 |
| 2016 | Dec 30, 2016 | 106.8× | – |
See a number that looks wrong?